Vor Biopharma Names Han Choi as Chief Financial Officer

MT Newswires Live09-30

Vor Biopharma (VOR) said Monday that Han Choi was named as its chief financial officer, effective immediately.

Choi previously served as a principal at Oracle Investment Management, a hedge fund focused on healthcare investments, said Vor Biopharma.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment